Since the truncated TG2 isoform escapes GTP inhibition and expresses a unique alternative C-terminal peptide, we hypothesise its participation in the steps leading to PCa progression and androgen independency of metastatic disease. Here, TGM2 is linked to metastatic neoplasm.